SP
CVS icon

Symmetry Partners’s CVS Health CVS Stock Holding History

Symmetry Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$979K Buy
9,463
+3,656
+63% +$326K 0.05% 87
2026
Q1 		$417K Sell
5,807
-2,896
-33% -$223K 0.02% 115
2025
Q4 		$691K Buy
8,703
+2,877
+49% +$227K 0.04% 88
2025
Q3 		$439K Buy
5,826
+141
+2% +$9.66K 0.05% 94
2025
Q2 		$392K Sell
5,685
-751
-12% -$49.2K 0.05% 96
2025
Q1 		$436K Sell
6,436
-42
-0.6% -$2.51K 0.06% 90
2024
Q4 		$291K Buy
+6,478
New +$363K 0.04% 102
2024
Q3 		– Sell
-7,795
Closed -$460K – 193
2024
Q2 		$460K Sell
7,795
-1,002
-11% -$62.7K 0.02% 301
2024
Q1 		$702K Hold
8,797
– – 0.05% 233
2023
Q4 		$695K Sell
8,797
-5,621
-39% -$400K 0.04% 225
2023
Q3 		$1.01M Sell
14,418
-1,024
-7% -$72.6K 0.05% 179
2023
Q2 		$1.07M Sell
15,442
-5,361
-26% -$381K 0.06% 185
2023
Q1 		$1.55M Buy
20,803
+3,608
+21% +$303K 0.09% 125
2022
Q4 		$1.6M Sell
17,195
-3,565
-17% -$344K 0.09% 118
2022
Q3 		$1.98M Hold
20,760
– – 0.13% 88
2022
Q2 		$1.92M Sell
20,760
-14,105
-40% -$1.38M 0.13% 85
2022
Q1 		$3.53M Hold
34,865
– – 0.22% 54
2021
Q4 		$3.6M Buy
34,865
+15,822
+83% +$1.46M 0.23% 60
2021
Q3 		$1.59M Sell
19,043
-500
-3% -$41.9K 0.1% 126
2021
Q2 		$1.63M Sell
19,543
-1,703
-8% -$139K 0.11% 129
2021
Q1 		$1.6M Buy
21,246
+865
+4% +$63K 0.11% 123
2020
Q4 		$1.39M Sell
20,381
-5,959
-23% -$388K 0.11% 130
2020
Q3 		$1.54M Buy
26,340
+10,014
+61% +$623K 0.13% 103
2020
Q2 		$1.06M Buy
16,326
+7,033
+76% +$443K 0.13% 77
2020
Q1 		$551K Buy
+9,293
New +$620K 0.12% 90

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Symmetry Partners's CVS Position: Q2 2026 in Review

Symmetry Partners increased its CVS Health (CVS) stake by 63% in Q2 2026, buying an estimated $326K and bringing the position to 9,463 shares worth $979K. The position accounts for 0.05% of the portfolio, ranked #87.

Symmetry Partners first reported a position in CVS in Q1 2020 and has held it in 25 quarters since. The position peaked at $3.6M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Symmetry Partners held 9,463 shares of CVS Health worth $979K as of Q2 2026.
  • Symmetry Partners bought 3,656 CVS Health shares in Q2 2026, an estimated $326K.
  • CVS Health made up 0.05% of Symmetry Partners's portfolio in Q2 2026, its #87 holding.
  • Symmetry Partners first reported a position in CVS Health in Q1 2020 and has held it in 25 quarters since.
  • Symmetry Partners's CVS Health position peaked at $3.6M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Symmetry Partners's 13F filing for Q2 2026, filed 23 Jul 2026.